316 related articles for article (PubMed ID: 32296163)
1. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
[No Abstract] [Full Text] [Related]
2. Interpretation and reporting of large regions of homozygosity and suspected consanguinity/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
Gonzales PR; Andersen EF; Brown TR; Horner VL; Horwitz J; Rehder CW; Rudy NL; Robin NH; Thorland EC; On Behalf Of The Acmg Laboratory Quality Assurance Committee
Genet Med; 2022 Feb; 24(2):255-261. PubMed ID: 34906464
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence to support recommendation for prenatal uniparental disomy (UPD) analysis following mosaic embryo transfer.
Mounts EL; Besser AG
Genet Med; 2021 Jan; 23(1):230-231. PubMed ID: 32814849
[No Abstract] [Full Text] [Related]
4. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
[No Abstract] [Full Text] [Related]
5. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
[No Abstract] [Full Text] [Related]
6. The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Grebe TA; Khushf G; Chen M; Bailey D; Brenman LM; Williams MS; Seaver LH;
Genet Med; 2020 Sep; 22(9):1431-1436. PubMed ID: 32475985
[No Abstract] [Full Text] [Related]
7. Mosaic genome-wide maternal isodiploidy: an extreme form of imprinting disorder presenting as prenatal diagnostic challenge.
Bens S; Luedeke M; Richter T; Graf M; Kolarova J; Barbi G; Lato K; Barth TF; Siebert R
Clin Epigenetics; 2017; 9():111. PubMed ID: 29046733
[TBL] [Abstract][Full Text] [Related]
8. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
[No Abstract] [Full Text] [Related]
9. [Expert consensus on the prenatal diagnosis and genetic counseling for uniparental disomy-related imprinting disorders].
Cyto And Genomics Group Of Medical Genetics Branch Of Chinese Medical Association ; Liu N; Shi P; Liu L; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jun; 41(6):685-695. PubMed ID: 38818552
[TBL] [Abstract][Full Text] [Related]
10. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
[No Abstract] [Full Text] [Related]
11. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chung WK; Kearney HM; Monaghan KG; Rehder CW; Chao EC;
Genet Med; 2019 Jun; 21(6):1267-1270. PubMed ID: 31015575
[No Abstract] [Full Text] [Related]
12. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
13. Response to Mounts and Besser.
Raca G; Shinawi M; Gaudio DD;
Genet Med; 2021 Jan; 23(1):240-242. PubMed ID: 32814848
[No Abstract] [Full Text] [Related]
14. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
[No Abstract] [Full Text] [Related]
15. Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Williams HE; Aiyar L; Dinulos MB; Flannery D; McClure ML; Lloyd-Puryear MA; Sanghavi K; Trotter TL; Viskochil D;
Genet Med; 2022 Nov; 24(11):2211-2219. PubMed ID: 36040445
[No Abstract] [Full Text] [Related]
16. The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Abu-El-Haija A; Reddi HV; Wand H; Rose NC; Mori M; Qian E; Murray MF;
Genet Med; 2023 May; 25(5):100803. PubMed ID: 36920474
[No Abstract] [Full Text] [Related]
17. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
[No Abstract] [Full Text] [Related]
18. Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Peña LDM; Burrage LC; Enns GM; Esplin ED; Harding C; Mendell JR; Niu ZN; Scharfe C; Yu T; Koeberl DD;
Genet Med; 2023 Jun; 25(6):100831. PubMed ID: 37031408
[No Abstract] [Full Text] [Related]
19. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
[No Abstract] [Full Text] [Related]
20. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
